Kurtz, Stephen E.
Eide, Christopher A.
Kaempf, Andy
Mori, Motomi
Tognon, Cristina E.
Borate, Uma
Druker, Brian J.
Tyner, Jeffrey W.
Article History
Received: 18 May 2018
Revised: 25 June 2018
Accepted: 4 July 2018
First Online: 6 August 2018
Compliance with ethical standards
:
: JWT receives research support from Agios, Aptose, Array, AstraZeneca, Constellation, Genentech, Gilead, Incyte, Janssen, Seattle Genetics, Syros, Takeda; JWT is a co-founder of Leap Oncology. BJD serves on the advisory boards for Gilead, Aptose, and Blueprint Medicines. BJD is principal investigator or coinvestigator on Novartis and BMS clinical trials. His institution, OHSU, has contracts with these companies to pay for patient costs, nurse and data manager salaries, and institutional overhead. He does not derive salary, nor does his laboratory receive funds from these contracts. The authors certify that the drugs tested in this study were chosen without input from any of our industry partners. The remaininig authors declare that they have no conflict of interest.